Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Recurrent/Metastatic Adenoid Cystic Carcinoma
NCT00886132Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jan 2007
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in adenoid cystic carcinoma (ACC), sponsored by University Health Network. Primary endpoint: Objective Response Rate. Started Jan 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT00886132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886132.